SavedAdd your journal

Journals / Retina-Vitreus / 2014 / Cilt: 22 - Sayı: 3

Intravitreal aflibercept treatment in acute unilateral non-arteritic optic neuropathy

Unilateral akut non-arteritik iskemik optik nöropatide intravitreal aflibersept tedavisi

Oya DÖNMEZ
Gamze KOCAOĞLU
Aylin YAMAN
MELTEM FATMA SÖYLEV BAJİN
A. Osman SAATCİ
Pages
221–225
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this case report is to present the intravitreal aflibercept injection in unilateral non-arteritic ischemic optic neuropathy and discuss the place of intravitreal anti-VEGFs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute non-arteritic ischemic optic neuropathy is the most common optic neuropathy in the elderly population and character- ised by unilateral painless sudden visual loss.
📊
Key Findings & Data:A 58-year-old man with sudden painless visual loss in his right eye of four days’duration was diagnosed to have acute non-arteritic isch- emic optic neuropathy. 2 mg intravitreal aflibercept injection was given once.
💡
Conclusion & Impact:The aim of this case report is to present the intravitreal aflibercept injection in unilateral non-arteritic ischemic optic neuropathy and discuss the place of intravitreal anti-VEGFs.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Acute non-arteritic ischemic optic neuropathy is the most common optic neuropathy in the elderly population and character- ised by unilateral painless sudden visual loss. Currently, there is not a well-established treatment modality. A 58-year-old man with sudden painless visual loss in his right eye of four days’duration was diagnosed to have acute non-arteritic isch- emic optic neuropathy. 2 mg intravitreal aflibercept injection was given once. The aim of this case report is to present the intravitreal aflibercept injection in unilateral non-arteritic ischemic optic neuropathy and discuss the place of intravitreal anti-VEGFs.

Özet

Non-arteritik iskemik optik nöropati tek gözde ağrısız ani görme kaybı ile karakterize ileri yaşta en sık görülen optik nöropatidir. Halen altın standart olarak kabul edilmiş etkin bir tedavi yöntemi bulunmamaktadır. Kliniğimize sağ gözde 4 gündür görme keskinliğinde azalma şikayeti ile başvuran ve akut non-arteritik iskemik optik nöropati tanısı konan 58 yaşındaki erkek hastaya bir kez intravitreal 2 mg aflibersept tedavisi uygulanmıştır. Bu olgu sunumunun amacı intra- vitreal aflibersept tedavisi uygulanan olgu bağlamında akut non-arteritik iskemik optik nöropati tedavisinde intravitreal anti-VEGF uygulamasını tartışmaktır.

🔖

Cite This Article

DÖNMEZ, O., KOCAOĞLU, G., YAMAN, A., BAJİN, M. F. S., SAATCİ, A. O. (2014). Intravitreal aflibercept treatment in acute unilateral non-arteritic optic neuropathy. Retina-Vitreus, Cilt: 22 - Sayı: 3, 221–225. https://ajindex.com/articles/305028

References (16)

  1. Hayreh SS. Anterior ischemic optic neuropathy I. Terminol- ogy and pathogenesis. Br J Ophthalmol 1974;58:955-63
  2. Newman N, Scherer R, Kelman S et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompres- sion trial follow-up study. Am J Ophthalmol 2002;134:317-28
  3. Hayreh SS, Joos KM, Podhajsky PA et al. Systemic disease associated with nonarteritic ischemic optic neuropathy. Am J Ophthalmol 1994;118:766-80
  4. Bajin MS, Selver OB, Taskin O et al. Single intravitreal ra- nibizumab injection in eyes with acute non-arteritic anterior ischaemic optic neuropathy. Clin Exp Optom 2011;94:367-70
  5. Hayreh SS. Anterior ischaemic optic neuropathy III. Treat- ment, prophylaxis and differential diagnosis. Br J Ophthal- mol 1974;58:981-9
  6. Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for the non-arterit- ic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995;273:625-32
  7. Rootman DB, Gill HS, Margolin EA. Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neu- ropathy: a prospective trial. Eye 2013;27:538-44
  8. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 2008;246:1029-46
  9. Yaman A, Selver OB, Saatci AO et al. Intravitreal triamcino- lone acetonide injection for acute non-arteritic anterior isch- aemic optic neuropathy. Clin Exp Optom 2008;91:561-4
  10. Kaderli B, Avci R, Yucel A et al. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2007;27:164-8
  11. Saatci AO, Taskin O, Selver OB et al. Efficacy of intravit- real ranibizumab injection in acute nonarteritic ischemic op- tic neuropathy: a long-term follow up. Open Ophthalmol J. 2013;7:58-62
  12. Çetin EN,Akduman L. Non-arteritik iskemik optik nöropatide intravitreal bevasizumab tedavisi. Ret-Vit 2013;21:295-98
  13. Olver JM, Spalton DJ, McCarney ACE. Microvascular study of the retrolaminar optic nerve in man. The possible signifi- cance in anterior ischemic optic neuropathy. Eye 1990;4:7-24
  14. Arnold AC. Pathogenesis of nonarteritic anterior ischemic op- tic neuropathy J Neuro-Ophthalmol 2003;23:157-63
  15. Menzi J, Korner F. Systemic corticosteroid theraphy in non- arteritic anterior ischemic optic neuropathy. Klin Monatsbl Augenheilkd 1992;200:349-53
  16. Patel S, Lee Y.